| Phase 4 |
| NCT05403047 |
Efficacy of Tenofovir Disoproxil on Mother-to-child Transmission of HBV in Tokombéré… |
Hepatitis B Virus - Chronic Active |
Active, Not Recruiting |
2026-10-14 |
| NCT07098481 |
Access to Hepatitis C Treatment in Cameroon: Comparison of a Simplified Test and Treat… |
Hepatitis C Virus Infection |
Not Yet Recruiting |
2025-08-01 |
| Phase 3 |
| NCT05813964 |
Efficacy, Acceptability and Safety of Event-driven HIV PrEP Using TAF/FTC in MSM in… |
HIV/AIDS |
Recruiting |
2026-09-02 |
| NCT06203132 |
DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People… |
HIV-1-infection |
Recruiting |
2026-07-27 |
| NCT04145258 |
Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous… |
Tuberculous Meningitis |
Recruiting |
2026-06-24 |
| NCT05597735 |
Assessment of the Efficacy and Safety of Tecovirimat in Patients With Monkeypox Virus… |
Monkeypox |
Active, Not Recruiting |
2026-05-26 |
| NCT06841614 |
EBOla Post-Exposure Prophylaxis |
Ebola Virus Disease |
Not Yet Recruiting |
2026-01-22 |
| NCT06273943 |
Impact of Long-acting Injectable Cabotegravir for HIV PrEP in MSM in France. |
Prevention |
Not Yet Recruiting |
2024-02-23 |
| Phase 2 |
| NCT05587894 |
OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized… |
COVID-19 |
Recruiting |
2026-02-23 |
| NCT05590455 |
Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis |
Tuberculous Meningitis |
Recruiting |
2025-12-15 |
| NCT05300035 |
Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1… |
HIV/AIDS and Infections |
Recruiting |
2024-12-27 |
| NCT07851337 |
Immunotherapy With Glatiramer Acetate in PLWHIV in Poor Immunological Responders on… |
HIV - Human Immunodeficiency Virus |
Not Yet Recruiting |
2026-10-01 |
| NCT05202288 |
Impact of Delay Between Administration of Inmazeb Administration and Vaccination by… |
Ebola Virus Disease |
Not Yet Recruiting |
2026-01-22 |
| NCT07081763 |
Immunotherapy With Baricitinib and Sirolimus, Alone and in Combination, for the Control… |
HIV-1-infection |
Not Yet Recruiting |
2025-07-23 |
| NCT06338826 |
Study Evaluating the Safety, in Terms of HBV Virological Control At 96 Weeks, of 2… |
HIV Infections |
Not Yet Recruiting |
2025-02-05 |
| Phase 1/2 |
| NCT06821126 |
Study Comparing Safety and Immunogenicity of Intranasal COVID-19 Vaccine and mRNA Booster… |
Healthy |
Recruiting |
2025-12-18 |
| NCT06255626 |
Safety and Immunogenicity of a Sub-unit Protein CD40.RBDv Bivalent COVID-19 Vaccine… |
COVID-19 |
Recruiting |
2025-04-25 |
| NCT07113106 |
Dose Escalation Trial of CD40.Pan.CoV Vaccine, Adjuvanted or Not, as a Booster in Adult… |
Healthy Volunteers |
Active, Not Recruiting |
2026-05-05 |
| Early Phase 1 |
| NCT07605520 |
An Experimental Medicine Multicenter Trial to Evaluate the Safety and Immunogenicity of… |
Healthy Adults |
Recruiting |
2026-06-02 |
| Not applicable |
| NCT07054359 |
"HBV unIversal vs Point-Of-Care-based Antiviral treatMent to Prevent Mother-to-child… |
HBV Infection |
Recruiting |
2026-10-08 |
| NCT01520844 |
the ANRS CO21 " Extreme " Cohort (CODEX) |
HIV Infection |
Recruiting |
2026-04-07 |
| NCT06522256 |
Identification of Molecular Signatures of High-risk Oncogenic HPV and Study of Their… |
HPV Infection |
Recruiting |
2025-12-04 |
| NCT05655702 |
DRug Use & Infections in ViEtnam: TuBerculosis Control |
Tuberculosis |
Recruiting |
2025-01-30 |
| NCT07656077 |
Intestinal Tissue-Resident Memory T Cells and HIV-1 Persistence During Antiretroviral… |
HIV-1 Infection |
Not Yet Recruiting |
2026-06-18 |
| NCT07592429 |
Assessment of Immune Memory - Humoral and Cellular - in mPOX-infected Patients : an… |
Mpox (Monkeypox) |
Not Yet Recruiting |
2026-05-18 |